The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma

Bedke, Jens; Albiges, Laurence; Capitanio, Umberto; Giles, Rachel H.; Hora, Milan; Ljungberg, Borje; Marconi, Lorenzo; Klatte, Tobias; Volpe, Alessandro; Abu-Ghanem, Yasmin; Dabestani, Saeed; Fernandez-Pello, Sergio; Hofmann, Fabian; Kuusk, Teele; Tahbaz, Rana; Powles, Thomas; Bex, Axel

dc.contributor.author	Bedke, Jens
dc.date.accessioned	2023-10-10T08:10:26Z
dc.date.available	2023-10-10T08:10:26Z
dc.date.issued	2023
dc.identifier.issn	0302-2838
dc.identifier.uri	http://hdl.handle.net/10900/146095
dc.language.iso	en	de_DE
dc.publisher	Elsevier	de_DE
dc.relation.uri	http://dx.doi.org/10.1016/j.eururo.2022.10.010	de_DE
dc.subject.ddc	610	de_DE
dc.title	The 2022 Updated European Association of Urology Guidelines on the Use of Adjuvant Immune Checkpoint Inhibitor Therapy for Renal Cell Carcinoma	de_DE
dc.type	Article	de_DE
utue.quellen.id	20230619000000_01656
utue.publikation.seiten	10-14	de_DE
utue.personen.roh	Bedke, Jens
utue.personen.roh	Albiges, Laurence
utue.personen.roh	Capitanio, Umberto
utue.personen.roh	Giles, Rachel H.
utue.personen.roh	Hora, Milan
utue.personen.roh	Ljungberg, Borje
utue.personen.roh	Marconi, Lorenzo
utue.personen.roh	Klatte, Tobias
utue.personen.roh	Volpe, Alessandro
utue.personen.roh	Abu-Ghanem, Yasmin
utue.personen.roh	Dabestani, Saeed
utue.personen.roh	Fernandez-Pello, Sergio
utue.personen.roh	Hofmann, Fabian
utue.personen.roh	Kuusk, Teele
utue.personen.roh	Tahbaz, Rana
utue.personen.roh	Powles, Thomas
utue.personen.roh	Bex, Axel
dcterms.isPartOf.ZSTitelID	European Urology	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	83	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE